Morphine Withdrawal-induced Diarrhoea and Acetic Acid-induced Abdominal Constriction: Animal Models for the Evaluation of 5-HT3 Ligands in the Treatment of Irritable Bowel Syndrome

Author： Veeranjaneyulu A.   Sridhar N.   babu r.j.   Gupta c.n.v.h.b.   Malavika R.   Shobana S.K.S.  

Publisher： Pharmaceutical Press

ISSN： 1460-8081

Source： Pharmacy and Pharmacology Communications, Vol.6, Iss.11, 2000-11, pp. : 513-516

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tegaserod: a new 5-HT4 agonist in the treatment of irritable bowel syndrome

By Tack Jan   Corsetti Maura  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 8, 2002-08 ,pp. : 1211-1218

Informa Healthcare

Access to resources Recommend Favorite

Crofelemer is promising for the treatment for patients with diarrhoea-predominant irritable bowel syndrome

By  

Inpharma, Vol. 1, Iss. 1590, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Safety Profile of Tegaserod, a 5-HT 4 Receptor Agonist, for the Treatment of Irritable Bowel Syndrome

By Hasler W.L.   Schoenfeld P.  

Drug Safety, Vol. 27, Iss. 9, 2004-01 ,pp. : 619-631

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Serotonin Receptor Ligands in the Treatment of Irritable Bowel Syndrome: A Review

By  

Current Drug Targets, Vol. 19, Iss. 15, 2018-12 ,pp. : 1774-1781

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of granisetron, a 5-HT 3 receptor antagonist, on morphine-induced potentiation of brain stimulation reward

By Rompre P.-P.   Injoyan R.   Hagan J.J.  

European Journal of Pharmacology, Vol. 287, Iss. 3, 1995-12 ,pp. : 263-269

Elsevier

Access to resources Recommend Favorite